Alkermes Plc
(NASDAQ : ALKS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.10%185.061.3%$523.39m
ARRYArray BioPharma Inc.
0.35%46.368.1%$429.27m
CELGCelgene Corporation
-5.44%93.531.3%$409.19m
GILDGilead Sciences, Inc.
-0.89%68.760.9%$404.38m
BIIBBiogen Inc.
-1.46%235.591.3%$375.33m
ILMNIllumina, Inc.
-0.78%358.753.5%$305.46m
REGNRegeneron Pharmaceuticals, Inc.
-2.76%311.432.6%$245.14m
VRTXVertex Pharmaceuticals Incorporated
-1.74%180.781.9%$224.95m
ALXNAlexion Pharmaceuticals, Inc.
-4.36%126.622.0%$202.33m
EXASExact Sciences Corporation
-1.23%114.2424.1%$194.88m
AAgilent Technologies, Inc.
-0.50%72.971.6%$181.30m
BMRNBioMarin Pharmaceutical Inc.
-2.66%85.574.3%$129.63m
INCYIncyte Corporation
-2.17%86.782.5%$116.12m
SRPTSarepta Therapeutics, Inc.
-1.47%127.9714.7%$112.72m
MRTXMirati Therapeutics Inc.
0.05%101.492.5%$102.03m

Company Profile

Alkermes Plc IS a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include the brands Aristada and Vivitrol. The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland.